HERON THERAPEUTICS, INC. /DE/ Interest Income (Expense), Net
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Interest Income (Expense), Net of -$160.00 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2016-08-08
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), net for the quarter ending 2016-06-30 was -$160.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), net for the quarter ending 2015-06-30 was -$93.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month |
|---|---|---|
| 2016-06-30 | -$160.00K 10-Q · filed 2016-08-08 | -$293.00K 10-Q · filed 2016-08-08 |
| 2015-06-30 | -$93.00K 10-Q · filed 2016-08-08 | -$303.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |